SCHEMBL2844559

SCHEMBL2844559

CCN1CCc2ccsc2C(Oc2ccc(C(N)=O)cc2Cl)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 1/20 0.37
HCRTR1 O43613 1/20 0.36
HCRTR2 O43614 1/20 0.36
CYP3A4 P08684 1/20 0.36
INSR P06213 1/20 0.35
ALK Q9UM73 1/20 0.35
TP53 P04637 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35
UTS2R Q9UKP6 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
DUSP3 P51452 1/20 0.33
PTPN5 P54829 1/20 0.33
PTPN11 Q06124 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2873210 0.87 UTS2R (0.37) OPRD1HCRTR1HCRTR2CYP3A4TP53
SCHEMBL2840993 0.86 OPRD1 (0.36) OPRD1UTS2RTPH1
SCHEMBL2842973 0.78 TPH1 (0.34) OPRD1INSRALKUTS2RSLC6A2
SCHEMBL2837709 0.77 TOP2A (0.36) OPRD1SLC6A2SLC6A4SLC6A3
SCHEMBL2841690 0.76 OPRD1 (0.40) OPRD1SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL2838274 0.73 SIGMAR1 (0.34) SLC6A4
SCHEMBL2836972 0.73 SLC6A4 (0.34) OPRD1UTS2RSLC6A2SLC6A4SLC6A3
SCHEMBL2837042 0.72 SIGMAR1 (0.36) HCRTR1HCRTR2CYP3A4KMT2AALDH1A1
Hydrochloric Acid SCHEMBL2839430 0.72 UTS2R (0.37) OPRD1UTS2RALDH1A1TPH1
SCHEMBL2839422 0.71 MEN1 (0.39) HCRTR1HCRTR2CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 OPRD1 1/4885HCRTR1 74/4885HCRTR2 112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.